Recent Activity

Loading...

SBIO

ALPS Medical Breakthroughs ETF · PSE

  • Category Equity
  • Expense Ratio 0.5%
  • Listing Date Dec 31, 2014
  • Volume 3,231.0
  • Market Cap (AUM) $106.87M

Performance

+2.59%

1W

+2.23%

1M

-11.43%

3M

+29.94%

6M

+2.18%

YTD

+6.73%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Summit Therapeutics IncSMMT5.14%
  • Vaxcyte, Inc.PCVX5.10%
  • Cerevel Therapeutics Holdings IncCERE4.95%
  • Viking Therapeutics, Inc.VKTX4.35%
  • Revolution Medicines, Inc.RVMD4.22%
  • Alkermes Public Limited CompanyALKS2.60%
  • Crinetics Pharmaceuticals IncCRNX2.37%
  • Axsome Therapeutics, Inc.AXSM2.36%
  • Merus N.V.MRUS2.23%
  • Corcept Therapeutics Incorporated.CORT2.17%

Technical Analysis of SBIO 2024-05-31

Overview:

In analyzing the technical indicators for SBIO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

  • Moving Averages (MA): The 5-day MA has been consistently below the closing price, ind...
See more ...

Recent News & Updates